Clin2
NCT05060783Possibly a fitRecruiting

Liquid blood test to help detect kidney cancer

Renal CancerOncocytoma

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether a “liquid biopsy” blood test can help detect kidney cancer when a CT scan looks suspicious but does not show cancer. It may help avoid unnecessary procedures or catch cancer patterns earlier, but it will depend on the type of kidney tumor and your situation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You had a CT scan because kidney cancer was suspected, but the scan did not show kidney cancer
  • If you have clear cell kidney cancer or oncocytoma, your diagnosis must be confirmed by a biopsy or surgical tissue sample
  • You can sign an informed consent form
  • You are able to complete the study procedures as planned
  • You likely need to be able to give blood samples for the liquid biopsy test

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06145139Enrolling by invitation
Liquid biopsy for kidney cancer: tracking tumor DNA after surgery

This study looks at whether a simple blood test can detect tiny bits of kidney cancer DNA after surgery. If successful, it could help doctors spot a return of cancer earlier than scans alone.

Aarhus N
NCT07874542Recruiting
Blood test to help classify kidney masses before surgery

This study looks at whether a simple blood test can help doctors tell if a kidney mass is cancer before surgery. It aims to improve how kidney masses are classified and guide treatment decisions.

Shanghai, Shanghai Municipality
NCT07776483Not yet recruiting
Blood test to predict immunotherapy response in rare kidney cancer

This study tests whether a simple blood test that tracks tumor DNA (called ctDNA) can help predict how well immunotherapy will work for people with non-clear cell kidney cancer. If you are about to start immunotherapy for advanced disease, this study could help your doctor better understand your treatment response.

NCT07649629Recruiting
Blood test to help diagnose advanced lung cancer

This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.

Roma, RM
NCT06422637Not yet recruiting
Early lung cancer screening using a blood test

This study tests a simple blood test to find lung cancer early, before symptoms appear. It may help detect cancer sooner, when treatment could be more effective.

Guangzhou, Guangdong
NCT05917106Recruiting
Testifying methylomics blood test for new kidney cancer monitoring

This study follows people with newly diagnosed kidney cancer who have not started treatment. It tests whether a special blood test can monitor the cancer over time, alongside standard follow-up after planned surgery.

Nanjing, Jiangsu

Hear when a new Renal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.